30Jul
Increased regulatory scrutiny of foreign direct investments in the healthcare sector
Key Takeaways - - Foreign Direct Investment (FDI) controls are proliferating around the globe. Since the pandemic, “health” has become a particular focus. - Several countries have adapted their existing FDI rules, or introduced new ones, to address concerns about national autonomy and supply chain disruption. Some of these changes are general, but some are specific to healthcare. - Plans for cross-border M&A in the healthcare sector should take close account of potential FDI screening...
By:
Dechert LLP
Related
The myriad and rapidly evolving impacts of COVID-19, the disease caused by the novel coronavirus, ar...
Read More >
For nearly 25 years, courts in the Ninth Circuit have consistently refused to sanction nonconsensual...
Read More >
On August 12, Governor Cuomo signed sweeping new legislation toughening and substantially broadening...
Read More >
The impending "expiration" of the Office of Management and Budget's (OMB) clearance on the most rece...
Read More >
Welcome to this special five-part podcast series with Jay Rosen, VP of Business Development for Affi...
Read More >
For certain healthcare transactions that will close on or after Jan. 1, 2020, parties to the transac...
Read More >